Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Bidwell Goetz

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Neurology|April 12, 2015
HIV status and the risk of ischemic stroke among menJason J Sico, Chung-Chou H Chang, Kaku So-Armah, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2015
Quality of HIV Care and Mortality Rates in HIV-Infected PatientsPhilip Todd Korthuis, Kathleen A McGinnis, Kevin L Kraemer, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Journal of the American Heart Association|October 18, 2014
HIV infection and cardiovascular disease in womenJulie A Womack, Chung-Chou H Chang, Kaku A So-Armah, et al.
JAMA Internal Medicine|March 6, 2013
HIV infection and the risk of acute myocardial infarctionMatthew S Freiberg, Chung-Chou H Chang, Lewis H Kuller, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
The Journal of Infectious Diseases|July 10, 2020
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE TrialTomas G Neilan, Kim-Lien Nguyen, Vlad G Zaha, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Neurology|April 12, 2015
HIV status and the risk of ischemic stroke among menJason J Sico, Chung-Chou H Chang, Kaku So-Armah, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2015
Quality of HIV Care and Mortality Rates in HIV-Infected PatientsPhilip Todd Korthuis, Kathleen A McGinnis, Kevin L Kraemer, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Journal of the American Heart Association|October 18, 2014
HIV infection and cardiovascular disease in womenJulie A Womack, Chung-Chou H Chang, Kaku A So-Armah, et al.
JAMA Internal Medicine|March 6, 2013
HIV infection and the risk of acute myocardial infarctionMatthew S Freiberg, Chung-Chou H Chang, Lewis H Kuller, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
The Journal of Infectious Diseases|July 10, 2020
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE TrialTomas G Neilan, Kim-Lien Nguyen, Vlad G Zaha, et al.
Pageof 17